Preliminary research turns to a fully implantable system ...

DUBLIN, Aug. 25, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, has received CE (Conformité Européenne) Mark approval for its Inceptiv™ closed-loop ...

—–In an interview with MedPage Today, Dr. Kapoor, from the Department of Pain Management at Cleveland Clinic, discusses the role of implantation of a permanent neuromodulation device in management of ...

The closed-loop feature of the Inceptiv SCS senses neural responses and is able to automatically adjust stimulation in real time. The Food and Drug Administration (FDA) has approved the Inceptiv ™ ...

Researchers at Johns Hopkins University School of Medicine say they have evidence from a new study in rats that spinal cord stimulation (SCS) may be useful in reducing chronic pain in people ...

Medtronic plc MDT recently received CE Mark approval for its Inceptiv closed-loop rechargeable spinal cord stimulator (SCS). The Inceptiv SCS system won't be sold or distributed in the United States ...

Based on 13 included studies (1561 patients), the researchers found that both conventional and novel SCS therapies were associated with superior efficacy vs conventional medical management. (HealthDay ...

Key Takeaways Spinal cord stimulation might improve arm strength among stroke survivorsSeven patients had improved arm ...

Chronic pain affects millions of individuals, considerably impacting their quality of life and emotional well-being. You may find that it alters your daily activities, leading to frustration and ...

KUTV — For patients suffering from chronic, severe back pain that hasn’t responded to traditional treatments, a spinal cord stimulator (SCS) may offer new hope. Dr. Jeff Pence, Interventional Spine ...

Spinal cord stimulation (SCS) therapies for chronic back and/or leg pain is superior to conventional medical management (CMM) for reduced pain intensity and functional disability, new research ...

Independent studies suggested that spinal cord stimulation improved chronic pain no more than placebo, but industry-funded critics cast doubt on these findings, researchers said. Recently published ...